-
STOK Dashboard
- Financials
- Filings
-
Holdings
-
Transcripts
- ETFs
- Insider
- Institutional
- Shorts
Stoke Therapeutics (STOK)
Company Profile
Quarter (USD) | Sep 24 | Jun 24 | Mar 24 | Dec 23 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 150.59 mm | 150.59 mm | 150.59 mm | 150.59 mm | 150.59 mm | 150.59 mm |
Cash burn (monthly) | 14.49 mm | 3.33 mm | 10.00 mm | 9.78 mm | 7.21 mm | 7.03 mm |
Cash used (since last report) | 73.61 mm | 16.92 mm | 50.81 mm | 49.67 mm | 36.61 mm | 35.70 mm |
Cash remaining | 76.98 mm | 133.66 mm | 99.77 mm | 100.92 mm | 113.98 mm | 114.89 mm |
Runway (months of cash) | 5.3 | 40.1 | 10.0 | 10.3 | 15.8 | 16.4 |
13F holders | Current |
---|---|
Total holders | 129 |
Opened positions | 29 |
Closed positions | 19 |
Increased positions | 38 |
Reduced positions | 42 |
13F shares | Current |
---|---|
Total value | 636.29 bn |
Total shares | 61.57 mm |
Total puts | 23.80 k |
Total calls | 3.00 k |
Total put/call ratio | 7.9 |
Largest owners | Shares | Value |
---|---|---|
Skorpios Trust | 6.91 mm | $76.18 bn |
BlackRock | 5.89 mm | $64.94 bn |
Lynx1 Capital Management | 5.19 mm | $57.21 bn |
RTW Investments | 5.12 mm | $56.51 bn |
Baker Bros. Advisors | 4.63 mm | $51.11 bn |
Redmile | 4.59 mm | $50.67 bn |
Cowen Financial Products | 3.72 mm | $19.58 mm |
MS Morgan Stanley | 3.44 mm | $37.91 bn |
TD The Toronto-Dominion Bank | 3.17 mm | $35.00 bn |
Vanguard | 2.73 mm | $30.13 bn |
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
30 Dec 24 | Kaye Edward M. MD | Common Stock | Option exercise | Acquire M | No | No | 0.6 | 35,000 | 21.00 k | 96,885 |
30 Dec 24 | Kaye Edward M. MD | Employee Stock Option Common Stock | Option exercise | Dispose M | No | No | 0.6 | 35,000 | 21.00 k | 567,801 |
23 Dec 24 | Skorpios Trust | Common Stock | Sell | Dispose S | Yes | No | 11.5 | 2,000,000 | 23.00 mm | 6,906,181 |
9 Dec 24 | Ticho Barry | Common Stock | Sell | Dispose S | No | No | 12.9913 | 2,586 | 33.60 k | 44,746 |
9 Dec 24 | Jonathan Allan | Common Stock | Sell | Dispose S | No | No | 12.9923 | 1,552 | 20.16 k | 21,476 |
9 Dec 24 | Jonathan Allan | Common Stock | Sell | Dispose S | No | Yes | 13.6878 | 12,114 | 165.81 k | 23,028 |
9 Dec 24 | Kaye Edward M. MD | Common Stock | Sell | Dispose S | No | No | 12.9912 | 6,786 | 88.16 k | 61,885 |